F7L (p.Phe7Leu) variant of CASQ2 (Calsequestrin-2)

F7L (p.Phe7Leu) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Cardiovascular phenotype; not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data and structural context.

F7L (p.Phe7Leu) variant details